Common thyroid drug tested to boost energy and heart health in dialysis patients
NCT ID NCT03977207
Summary
This study is testing whether levothyroxine, a common thyroid medication, can improve quality of life and heart health in people receiving dialysis. Researchers will give either the medication or a placebo to 336 dialysis patients with borderline thyroid levels for six months. They want to see if the medication helps patients feel better physically and slows heart artery calcification.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODIALYSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California Irvine
RECRUITINGOrange, California, 92868, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.